Bacterial genetic determinants of non-O157 STEC outbreaks and hemolytic-uremic syndrome after infection.
about
Bacterial Factors Associated with Lethal Outcome of Enteropathogenic Escherichia coli Infection: Genomic Case-Control Studies.Isolation and genetic characterization of a coinfection of non-O157 Shiga toxin-producing Escherichia coliMolecular analysis as an aid to assess the public health risk of non-O157 Shiga toxin-producing Escherichia coli strains.The role of lymphostatin/EHEC factor for adherence-1 in the pathogenesis of gram negative infectionLow-density macroarray targeting non-locus of enterocyte effacement effectors (nle genes) and major virulence factors of Shiga toxin-producing Escherichia coli (STEC): a new approach for molecular risk assessment of STEC isolates.A comprehensive proteomic analysis of the type III secretome of Citrobacter rodentium.Differential gene expression and adherence of Escherichia coli O157:H7 in vitro and in ligated pig intestinesThe highly virulent 2006 Norwegian EHEC O103:H25 outbreak strain is related to the 2011 German O104:H4 outbreak strain.Association of nucleotide polymorphisms within the O-antigen gene cluster of Escherichia coli O26, O45, O103, O111, O121, and O145 with serogroups and genetic subtypesRecent advances in understanding enteric pathogenic Escherichia coli.Molecular risk assessment and epidemiological typing of Shiga toxin-producing Escherichia coli by using a novel PCR binary typing system.Assessing the public health risk of Shiga toxin-producing Escherichia coli by use of a rapid diagnostic screening algorithm.Incidence and virulence determinants of verocytotoxin-producing Escherichia coli infections in the Brussels-Capital Region, Belgium, in 2008-2010Norwegian sheep are an important reservoir for human-pathogenic Escherichia coli O26:H11.Applicability of phylogenetic methods for characterizing the public health significance of verocytotoxin-producing Escherichia coli strains.NleB, a bacterial effector with glycosyltransferase activity, targets GAPDH function to inhibit NF-κB activation.Genomic O island 122, locus for enterocyte effacement, and the evolution of virulent verocytotoxin-producing Escherichia coli.Towards a molecular definition of enterohemorrhagic Escherichia coli (EHEC): detection of genes located on O island 57 as markers to distinguish EHEC from closely related enteropathogenic E. coli strainsHigh rates of Escherichia coli transmission between livestock and humans in rural Uganda.Escherichia coli O157:H7 survives within human macrophages: global gene expression profile and involvement of the Shiga toxinsPathogenicity Island O-122 in enteropathogenic Escherichia coli strains is associated with diarrhea severity in children from Lima Peru.The bacterial virulence factor lymphostatin compromises intestinal epithelial barrier function by modulating rho GTPases.Discrimination of enterohemorrhagic Escherichia coli (EHEC) from non-EHEC strains based on detection of various combinations of type III effector genesA type III effector antagonizes death receptor signalling during bacterial gut infection.Always one step ahead: How pathogenic bacteria use the type III secretion system to manipulate the intestinal mucosal immune system.Hijacking of death receptor signaling by bacterial pathogen effectors.Genetic makeup of Shiga toxin-producing Escherichia coli in relation to clinical symptoms and duration of shedding: a microarray analysis of isolates from Swedish children.The role of Tir, EspA, and NleB in the colonization of cattle by Shiga toxin producing Escherichia coli O26:H11.Prevalence and characteristics of the O122 pathogenicity island in typical and atypical enteropathogenic Escherichia coli strains.EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammation.Distribution of pathogenicity islands OI-122, OI-43/48, and OI-57 and a high-pathogenicity island in Shiga toxin-producing Escherichia coli.Genomic diversity and virulence profiles of historical Escherichia coli O157 strains isolated from clinical and environmental sources.Production of verotoxin and distribution of O islands 122 and 43/48 among verotoxin-producing Escherichia coli O103:H2 isolates from cattle and humans.A distinct regulatory sequence is essential for the expression of a subset of nle genes in attaching and effacing Escherichia coli.Prevalence and characterization of non-O157 shiga toxin-producing Escherichia coli isolates from commercial ground beef in the United States.Regulation of expression and secretion of NleH, a new non-locus of enterocyte effacement-encoded effector in Citrobacter rodentiumCharacterization of Enterohemorrhagic Escherichia coli on Veal Hides and Carcasses.Multiplex real-time PCR assay for detection of Escherichia coli O157:H7 and screening for non-O157 Shiga toxin-producing E. coli.Scientific Opinion of the Panel on Biological Hazards (BIOHAZ) - Monitoring of verotoxigenic Escherichia coli (VTEC) and identification of human pathogenic VTEC typesScientific Opinion on the risk posed by Shiga toxin-producingEscherichia coli(STEC) and other pathogenic bacteria in seeds and sprouted seeds
P2860
Q30299938-70562426-B889-4CF2-BE1B-FE91C20D07A4Q33376522-DFB6B883-5194-4EA4-846C-D9A266AECA4CQ33378528-ED9AC495-90DA-4C44-8C25-AEED5D415D42Q33398124-E151602E-7C82-4872-965A-0C8771DEFB70Q33559553-4647C495-B297-43F4-91F0-D83CD3C47C1DQ33673874-F2F1584D-C63A-49BC-9672-FAB70229B1FBQ33841013-F800128D-C18B-45EE-B296-93DAC37CB985Q34189292-65F4932A-B506-4F01-8D03-0FE9ACCF2370Q34338238-645A3416-8A2F-474E-B05A-926352F448FAQ34375210-689842A0-9295-4D91-B051-6387E46EB788Q34739391-61637ED7-FC78-456E-8666-E96640E5B8B9Q35455807-41275F65-6680-4554-AEA8-6269529E8B11Q35867900-D789601E-395F-47DE-8C19-679662B216A2Q36018107-49F9D96B-F055-48E7-BF7D-EC527999A6AAQ36483051-1846CA22-33BB-4D98-BDB2-F36E84C2BACBQ36557738-9E782014-740A-4EC4-8F4A-C859A422D70DQ36845551-FE4CB36D-8B38-4BF9-9AD2-1356028EE8D5Q36884331-591EF63E-F972-4FF3-A28C-E710FB383D9CQ36933540-4FC2F1A2-4C08-48C1-A218-95FACBC79609Q36949983-800CEDFB-9742-4196-96FE-327CC2F9FD68Q36988186-98700D6A-4A3F-47A7-A88A-8C57157449F8Q37164543-113653CE-1EAC-4CE1-AD94-2C9D6AD5A2BBQ37264210-7BA637DF-B154-4AA8-86D0-C1CDCE2ED24CQ37331618-392DED10-A77D-4A4D-88A4-75EB654EB973Q37871646-8F0FEE26-C698-4DC1-BF32-17EF2BF02E46Q38295538-0E75E325-A610-4BC9-8904-063B1A70322CQ38831203-5827584C-9E44-4B76-84C9-BA214E1D3D8CQ39648124-184E04CC-0C04-4718-9D47-E3C2213B9A0BQ39900258-940DF44F-D4BD-49A6-ABF6-77B3F10B9E5CQ40372961-D9BFB858-3FE9-47AB-9811-A6F4BDA8C078Q40524748-0AFBC88B-525B-4ADB-A54A-41DEA1C447CDQ41671037-9168CE0F-5D0C-4BE4-8D24-83B64FE2FF77Q41766806-47A5AF93-3A67-480A-BF43-BBD7DD3849DCQ41902646-4A7825DB-CF3B-4CF2-9A55-FB09B39C3B9EQ42062054-7093B720-8F07-49A0-A94C-DB401C801E99Q42115897-012146F8-09E6-4CAE-8ADA-19235AE4839AQ43359997-3C54BEBE-D7E3-4C6C-AD14-AAEE8D7723EDQ46800667-D050AE49-9AE0-4BD6-B916-681FD6AF500AQ47145087-DC5043C0-61FF-4576-9317-3A3CE7DDB3E6Q47150758-12029938-178B-4389-81F4-EBF2855DC757
P2860
Bacterial genetic determinants of non-O157 STEC outbreaks and hemolytic-uremic syndrome after infection.
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Bacterial genetic determinants ...... emic syndrome after infection.
@ast
Bacterial genetic determinants ...... emic syndrome after infection.
@en
type
label
Bacterial genetic determinants ...... emic syndrome after infection.
@ast
Bacterial genetic determinants ...... emic syndrome after infection.
@en
prefLabel
Bacterial genetic determinants ...... emic syndrome after infection.
@ast
Bacterial genetic determinants ...... emic syndrome after infection.
@en
P2093
P50
P356
P1476
Bacterial genetic determinants ...... emic syndrome after infection.
@en
P2093
Alejandra Vazquez
B Brett Finlay
Claudia Lupp
Jose L Puente
Mariola Mascarenhas
Mark E Wickham
Nat F Brown
Wanyin Deng
P304
P356
10.1086/506620
P407
P577
2006-08-11T00:00:00Z